Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Talbot

Showing results (241-250 of 255) with videos related to

Pageof 26
Sort By:
Neurobiology of Aging|July 24, 2018
ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase functionMartina de Majo, Simon D Topp, Bradley N Smith, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 5, 2017
July 2017 ENCALS statement on edaravoneAmmar Al-Chalabi, Peter M Andersen, Siddharthan Chandran, et al.
Nucleic Acids Research|April 10, 2025
High-throughput screen of 100 000 small molecules in C9ORF72 ALS neurons identifies spliceosome modulators that mobilize G4C2 repeat RNA into nuclear export and repeat associated non-canonical translationMaartje J Luteijn, Varun Bhaskar, Dominic Trojer, et al.
Nature Communications|August 29, 2024
ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypesRenata Vieira de Sá, Emma Sudria-Lopez, Marta Cañizares Luna, et al.
Journal of Medical Genetics|April 8, 2014
A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratoriesChizuru Akimoto, Alexander E Volk, Marka van Blitterswijk, et al.
The Journal of Clinical Investigation|August 14, 2020
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementiaMercedes Prudencio, Jack Humphrey, Sarah Pickles, et al.
The Lancet. Neurology|March 31, 2018
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction modelHenk-Jan Westeneng, Thomas P A Debray, Anne E Visser, et al.
The Lancet. Neurology|March 13, 2012
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyElisa Majounie, Alan E Renton, Kin Mok, et al.
Science Translational Medicine|May 5, 2017
Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosisBradley N Smith, Simon D Topp, Claudia Fallini, et al.
American Journal of Medical Genetics. Part A|October 8, 2020
Leukoencephalopathy with calcifications and cysts: Genetic and phenotypic spectrumYanick J Crow, Heather Marshall, Gillian I Rice, et al.
Pageof 26

Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
Neurobiology of Aging|July 24, 2018
ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase functionMartina de Majo, Simon D Topp, Bradley N Smith, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 5, 2017
July 2017 ENCALS statement on edaravoneAmmar Al-Chalabi, Peter M Andersen, Siddharthan Chandran, et al.
Nucleic Acids Research|April 10, 2025
High-throughput screen of 100 000 small molecules in C9ORF72 ALS neurons identifies spliceosome modulators that mobilize G4C2 repeat RNA into nuclear export and repeat associated non-canonical translationMaartje J Luteijn, Varun Bhaskar, Dominic Trojer, et al.
Nature Communications|August 29, 2024
ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypesRenata Vieira de Sá, Emma Sudria-Lopez, Marta Cañizares Luna, et al.
Journal of Medical Genetics|April 8, 2014
A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratoriesChizuru Akimoto, Alexander E Volk, Marka van Blitterswijk, et al.
The Journal of Clinical Investigation|August 14, 2020
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementiaMercedes Prudencio, Jack Humphrey, Sarah Pickles, et al.
The Lancet. Neurology|March 31, 2018
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction modelHenk-Jan Westeneng, Thomas P A Debray, Anne E Visser, et al.
The Lancet. Neurology|March 13, 2012
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyElisa Majounie, Alan E Renton, Kin Mok, et al.
Science Translational Medicine|May 5, 2017
Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosisBradley N Smith, Simon D Topp, Claudia Fallini, et al.
American Journal of Medical Genetics. Part A|October 8, 2020
Leukoencephalopathy with calcifications and cysts: Genetic and phenotypic spectrumYanick J Crow, Heather Marshall, Gillian I Rice, et al.
Pageof 26